| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent developments have positively influenced product and service offerings, particularly with the successful Phase 3 studies of upadacitinib, demonstrating strong efficacy in treating vitiligo. This provides a significant boost to AbbVie's reputation in dermatological treatments and highlights their focus on innovative solutions in this field. Additionally, ongoing research and clinical trials are reinforcing the company's dedication to advancing dermatological care. However, challenges in regulatory hurdles and market competition could impact the pace of development. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.2 on 2025-10-29. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-29 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2025-10-28 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| 2025-10-27 | 0%(0%) | 0 | 0% | 0.2 | 2.3 | -1 | |||||||
| 2025-10-26 | 0%(0%) | 0 | 0% | 0.3 | 2.9 | -1 | |||||||
| 2025-10-25 | 0%(0%) | 0 | 0% | 0.3 | 2.9 | -1 | |||||||
| 2025-10-24 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-10-23 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-10-22 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-10-21 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-10-20 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-29 17:03:22 The positive results from clinical trials could lead to favorable financial implications for AbbVie in the market. |
| 2025-10-29 17:03:22 The ongoing research represented in clinical trials emphasizes the commitment to advancements in dermatological treatments. |
| 2025-10-29 17:03:22 The focus on autoimmune conditions like vitiligo reflects a growing trend in developing targeted therapies. |
| 2025-10-29 17:03:22 The discussion of vitiligo as a chronic autoimmune disease underscores the broader implications for patient confidence and daily life. |
| 2025-10-29 17:03:22 The article highlights the successful results from Phase 3 studies of upadacitinib, showing its efficacy in treating vitiligo. |